MicroRNAs: Toward the clinic for breast cancer patients

Seminars in Oncology

Volumn 38, Issue 6, 2011, Pages 764-775

  Ferracin, Manuela ^a   Querzoli, Patrizia ^a   Calin, George A ^b   Negrini, Massimo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; DIAGNOSTIC VALUE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC VARIABILITY; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICRORNAS; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 81155124249     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.08.005     Document Type: Article

References (136)

1. M.H. Galea, R.W. Blamey, C.E. Elston, and I.O. Ellis The Nottingham Prognostic Index in primary breast cancer Breast Cancer Res Treat 22 1992 207 219
2. A. Goldhirsch, J.N. Ingle, R.D. Gelber, A.S. Coates, B. Thurlimann, and H.J. Senn Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 Ann Oncol 20 2009 1319 1329
3. M.V. Iorio, M. Ferracin, and C.G. Liu MiRNA gene expression deregulation in human breast cancer Cancer Res 65 2005 7065 7070
4. J. Le Quesne, and C. Caldas Micro-RNAs and breast cancer Mol Oncol 4 2010 230 241
5. Z. Yu, R. Baserga, L. Chen, C. Wang, M.P. Lisanti, and R.G. Pestell miRNA, cell cycle, and human breast cancer Am J Pathol 176 2010 1058 1064
6. F. Yu, H. Yao, and P. Zhu let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 2007 1109 1123
7. G.K. Scott, A. Goga, D. Bhaumik, C.E. Berger, C.S. Sullivan, and C.C. Benz Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b J Biol Chem 282 2007 1479 1486
8. Z. Yu, N.E. Willmarth, and J. Zhou miRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling Proc Natl Acad Sci U S A 107 2010 8231 8236
9. Z. Yu, C. Wang, and M. Wang A cyclin D1/miRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 2008 509 517
10. A. Hossain, M.T. Kuo, and G.F. Saunders Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA Mol Cell Biol 26 2006 8191 8201
11. H. Li, C. Bian, L. Liao, J. Li, and R.C. Zhao miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1 Breast Cancer Res Treat 126 2010 565 575
12. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
13. P.A. Gregory, A.G. Bert, and E.L. Paterson The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 2008 593 601
14. M. Korpal, E.S. Lee, G. Hu, and Y. Kang The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J Biol Chem 283 2008 14910 14914
15. S.M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev 22 2008 894 907
16. H. Wu, S. Zhu, and Y.Y. Mo Suppression of cell growth and invasion by miR-205 in breast cancer Cell Res 19 2009 439 448
17. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by miRNA-10b in breast cancer Nature 449 2007 682 688
18. L. Ma, F. Reinhardt, and E. Pan Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nat Biotechnol 28 2010 341 347
19. Q. Huang, K. Gumireddy, and M. Schrier The miRNAs miR-373 and miR-520c promote tumour invasion and metastasis Nat Cell Biol 10 2008 202 210
20. S. Zhu, H. Wu, F. Wu, D. Nie, S. Sheng, and Y.Y. Mo MiRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Res 18 2008 350 359
21. Z. Lu, M. Liu, and V. Stribinskis MiRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene Oncogene 27 2008 4373 4379
22. L. Qi, J. Bart, and L.P. Tan Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma BMC Cancer 9 2009 163
23. G.L. Huang, X.H. Zhang, and G.L. Guo Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma Oncol Rep 21 2009 673 679
24. S.F. Tavazoie, C. Alarcon, and T. Oskarsson Endogenous human miRNAs that suppress breast cancer metastasis Nature 451 2008 147 152
25. G. Martello, A. Rosato, and F. Ferrari A MiRNA targeting dicer for metastasis control Cell 141 2010 1195 1207
26. C. Blenkiron, L.D. Goldstein, and N.P. Thorne MiRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biol 8 2007 R214
27. M.D. Mattie, C.C. Benz, and J. Bowers Optimized high-throughput miRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies Mol Cancer 5 2006 24
28. A.J. Lowery, N. Miller, and A. Devaney MiRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer Breast Cancer Res 11 2009 R27
29. B.D. Adams, H. Furneaux, and B.A. White The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines Mol Endocrinol 21 2007 1132 1147
30. N. Kondo, T. Toyama, H. Sugiura, Y. Fujii, and H. Yamashita miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer Cancer Res 68 2008 5004 5008
31. B.D. Adams, D.M. Cowee, and B.A. White The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells Mol Endocrinol 23 2009 1215 1230
32. D.P. Pandey, and D. Picard miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA Mol Cell Biol 29 2009 3783 3790
33. J. Xiong, D. Yu, and N. Wei An estrogen receptor alpha suppressor, miRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples FEBS J 277 2010 1684 1694
34. Y. Zhao, C. Deng, and J. Wang Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer Breast Cancer Res Treat 127 2010 69 80
35. R. Spizzo, M.S. Nicoloso, and L. Lupini miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells Cell Death Differ 17 2010 246 254
36. P. Bhat-Nakshatri, G. Wang, and N.R. Collins Estradiol-regulated miRNAs control estradiol response in breast cancer cells Nucleic Acids Res 37 2009 4850 4861
37. G. Maillot, M. Lacroix-Triki, and S. Pierredon Widespread estrogen-dependent repression of miRNAs involved in breast tumor cell growth Cancer Res 69 2009 8332 8340
38. N.S. Wickramasinghe, T.T. Manavalan, S.M. Dougherty, K.A. Riggs, Y. Li, and C.M. Klinge Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res 37 2009 2584 2595
39. L. Castellano, G. Giamas, and J. Jacob The estrogen receptor-alpha- induced miRNA signature regulates itself and its transcriptional response Proc Natl Acad Sci U S A 106 2009 15732 15737
40. J.J. Zhao, J. Lin, and H. Yang MiRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer J Biol Chem 283 2008 31079 31086
41. G. Di Leva, P. Gasparini, and C. Piovan MiRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer J Natl Cancer Inst 102 2010 706 721
42. M.V. Iorio, P. Casalini, and C. Piovan miRNA-205 regulates HER3 in human breast cancer Cancer Res 69 2009 2195 2200
43. R. Duan, C. Pak, and P. Jin Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA Hum Mol Genet 16 2007 1124 1131
44. W. Li, R. Duan, F. Kooy, S.L. Sherman, W. Zhou, and P. Jin Germline mutation of miRNA-125a is associated with breast cancer J Med Genet 46 2009 358 360
45. J. Shen, C.B. Ambrosone, R.A. DiCioccio, K. Odunsi, S.B. Lele, and H. Zhao A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis Carcinogenesis 29 2008 1963 1966
46. Z. Hu, J. Liang, and Z. Wang Common genetic variants in pre-miRNAs were associated with increased risk of breast cancer in Chinese women Hum Mutat 30 2009 79 84
47. I. Catucci, R. Yang, and P. Verderio Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases Hum Mutat 31 2010 E1052 E1057
48. L.B. Gao, P. Bai, and X.M. Pan The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis Breast Cancer Res Treat 125 2010 571 574
49. A.E. Hoffman, T. Zheng, and C. Yi miRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis Cancer Res 69 2009 5970 5977
50. R. Yang, B. Schlehe, and K. Hemminki A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk Breast Cancer Res Treat 121 2010 693 702
51. S. Tchatchou, A. Jung, and K. Hemminki A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women Carcinogenesis 30 2009 59 64
52. F. Song, H. Zheng, and B. Liu An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset Clin Cancer Res 15 2009 6292 6300
53. P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating miRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
54. H.M. Heneghan, N. Miller, A.J. Lowery, K.J. Sweeney, J. Newell, and M.J. Kerin Circulating miRNAs as novel minimally invasive biomarkers for breast cancer Ann Surg 251 2010 499 505
55. H.M. Heneghan, N. Miller, R. Kelly, J. Newell, and M.J. Kerin Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease Oncologist 15 2010 673 682
56. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
57. K.H. Salter, C.R. Acharya, and K.S. Walters An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer PLoS One 3 2008 e1908
58. O. Kovalchuk, J. Filkowski, and J. Meservy Involvement of miRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Mol Cancer. Ther 7 2008 2152 2159
59. T.E. Miller, K. Ghoshal, and B. Ramaswamy MiRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1 J Biol Chem 283 2008 29897 29903
60. N. Yang, S. Kaur, and S. Volinia MiRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer Cancer Res 68 2008 10307 10314
61. I.P. Pogribny, J.N. Filkowski, V.P. Tryndyak, A. Golubov, S.I. Shpyleva, and O. Kovalchuk Alterations of miRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin Int J Cancer 127 2010 1785 1794
62. M. Zhou, Z. Liu, and Y. Zhao MiRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression J Biol Chem 285 2010 21496 21507
63. W. Kong, L. He, and M. Coppola MiRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer J Biol Chem 285 2010 17869 17879
64. R. Kulshreshtha, M. Ferracin, and S.E. Wojcik A miRNA signature of hypoxia Mol Cell Biol 27 2007 1859 1867
65. C. Camps, F.M. Buffa, and S. Colella hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer Clin Cancer Res 14 2008 1340 1348
66. J.A. Foekens, A.M. Sieuwerts, and M. Smid Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer Proc Natl Acad Sci U S A 105 2008 13021 13026
67. A.M. Krichevsky, and G. Gabriely miR-21: a small multi-faceted RNA J Cell Mol Med 13 2009 39 53
68. L.X. Yan, X.F. Huang, and Q. Shao MiRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis RNA 14 2008 2348 2360
69. B. Qian, D. Katsaros, and L. Lu High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1 Breast Cancer Res Treat 117 2009 131 140
70. F.G. Rodriguez-Gonzalez, A.M. Sieuwerts, and M. Smid MiRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer Breast Cancer Res Treat 127 2010 43 51
71. J. Krutzfeldt, N. Rajewsky, and R. Braich Silencing of miRNAs in vivo with 'antagomirs' Nature 438 2005 685 689
72. J. Stenvang, A.N. Silahtaroglu, M. Lindow, J. Elmen, and S. Kauppinen The utility of LNA in miRNA-based cancer diagnostics and therapeutics Semin Cancer Biol 18 2008 89 102
73. J. Kota, R.R. Chivukula, and K.A. O'Donnell Therapeutic miRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 2009 1005 1017
74. D. Iliopoulos, H.A. Hirsch, and K. Struhl An epigenetic switch involving NF-kappaB, Lin28, Let-7 MiRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
75. S. Varambally, Q. Cao, and R.S. Mani Genomic loss of miRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 2008 1695 1699
76. C.H. Moriarty, B. Pursell, and A.M. Mercurio miR-10b targets Tiam1: implications for Rac activation and carcinoma migration J Biol Chem 285 2010 20541 20546
77. C. Jin, H. Rajabi, and D. Kufe miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death Int J Oncol 37 2010 61 69
78. A.B. Hui, W. Shi, and P.C. Boutros Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues Lab Invest 89 2009 597 606
79. X. Guo, Y. Wu, and R.S. Hartley MiRNA-125a represses cell growth by targeting HuR in breast cancer RNA Biol 6 2009 575 583
80. M.H. Hofmann, J. Heinrich, G. Radziwill, and K. Moelling A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells Mol Cancer Res 7 2009 1635 1644
81. S. Komagata, M. Nakajima, S. Takagi, T. Mohri, T. Taniya, and T. Yokoi Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b Mol Pharmacol 76 2009 702 709
82. H. Rajabi, C. Jin, R. Ahmad, C. McClary, M.D. Joshi, and D. Kufe MUCIN 1 oncoprotein expression is suppressed by the miR-125b oncomir Genes Cancer 1 2010 62 68
83. P. Saetrom, J. Biesinger, and S.M. Li A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis Cancer Res 69 2009 7459 7465
84. L.F. Sempere, M. Preis, and T. Yezefski Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MiRNA expression in solid tumors Clin Cancer Res 16 2010 4246 4255
85. J. Zhang, Y.Y. Du, and Y.F. Lin The cell growth suppressor, mir-126, targets IRS-1 Biochem Biophys Res Commun 377 2008 136 140
86. S. Masri, Z. Liu, S. Phung, E. Wang, Y.C. Yuan, and S. Chen The role of miRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells Breast Cancer Res Treat 124 2010 89 990
87. M. Sachdeva, and Y.Y. Mo MiRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 Cancer Res 70 2010 378 387
88. S. Wang, C. Bian, and Z. Yang miR-145 inhibits breast cancer cell growth through RTKN Int J Oncol 34 2009 1461 1466
89. D. Bhaumik, G.K. Scott, S. Schokrpur, C.K. Patil, J. Campisi, and C.C. Benz Expression of miRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells Oncogene 27 2008 5643 5647
90. M. Persson, Y. Andren, J. Mark, H.M. Horlings, F. Persson, and G. Stenman Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck Proc Natl Acad Sci U S A 106 2009 18740 18744
91. S. Jiang, H.W. Zhang, and M.H. Lu MiRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Res 70 2010 3119 3127
92. W. Kong, H. Yang, and L. He MiRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA Mol Cell Biol 28 2008 6773 6784
93. X. Zhang, G. Wan, and S. Mlotshwa Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA damage signaling pathway Cancer Res 70 2010 7176 7186
94. L. Zhang, J. Huang, and N. Yang miRNAs exhibit high frequency genomic alterations in human cancer Proc Natl Acad Sci U S A 103 2006 9136 9141
95. J. Shen, C.B. Ambrosone, and H. Zhao Novel genetic variants in miRNA genes and familial breast cancer Int J Cancer 124 2009 1178 1182
96. H. Al-Nakhle, P.A. Burns, and M. Cummings Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer Cancer Res 70 2010 4778 4784
97. S. Cascio, A. D'Andrea, and R. Ferla miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells J Cell Physiol 224 2010 242 249
98. W.H. Liu, S.H. Yeh, and C.C. Lu MiRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells Gastroenterology 136 2009 683 693
99. J.S. Imam, K. Buddavarapu, and J.S. Lee-Chang MiRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers Oncogene 29 2010 4971 4979
100. R. Luthra, R.R. Singh, and M.G. Luthra MiRNA-196a targets annexin A1: a miRNA-mediated mechanism of annexin A1 downregulation in cancers Oncogene 27 2008 6667 6678
101. U. Burk, J. Schubert, and U. Wellner A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep 9 2008 582 589
102. D.R. Cochrane, N.S. Spoelstra, E.N. Howe, S.K. Nordeen, and J.K. Richer MiRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents Mol Cancer Ther 8 2009 1055 1066
103. Y. Shimono, M. Zabala, and R.W. Cho Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell 138 2009 592 603
104. S.I. Shpyleva, V.P. Tryndyak, and O. Kovalchuk Role of ferritin alterations in human breast cancer cells Breast Cancer Res Treat 126 2011 63 71
105. V.P. Tryndyak, F.A. Beland, and I.P. Pogribny E-cadherin transcriptional down-regulation by epigenetic and miRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells Int J Cancer 126 2010 2575 2583
106. S. Uhlmann, J.D. Zhang, and A. Schwager miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer Oncogene 29 2010 4297 4306
107. R. Baffa, M. Fassan, and S. Volinia MiRNA expression profiling of human metastatic cancers identifies cancer gene targets J Pathol 219 2009 214 221
108. S. Zhu, M.L. Si, H. Wu, and Y.Y. Mo MiRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 282 2007 14328 14336
109. L.B. Frankel, N.R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A.H. Lund Programmed cell death 4 (PDCD4) is an important functional target of the miRNA miR-21 in breast cancer cells J Biol Chem 283 2008 1026 1033
110. T. Li, D. Li, J. Sha, P. Sun, and Y. Huang MiRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells Biochem Biophys Res Commun 383 2009 280 285
111. Y. Yang, R. Chaerkady, M.A. Beer, J.T. Mendell, and A. Pandey Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach Proteomics 9 2009 1374 1384
112. E.C. Connolly, K. Van Doorslaer, L.E. Rogler, and C.E. Rogler Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB Mol Cancer Res 8 2010 691 700
113. B. Song, C. Wang, and J. Liu MiRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression J Exp Clin Cancer Res 29 2010 29
114. L.Y. Bourguignon, C.C. Spevak, G. Wong, W. Xia, and E. Gilad Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of miRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells J Biol Chem 284 2009 26533 26546
115. M.L. Si, S. Zhu, H. Wu, Z. Lu, F. Wu, and Y.Y. Mo miR-21-mediated tumor growth Oncogene 26 2007 2799 2803
116. M.E. Crosby, R. Kulshreshtha, M. Ivan, and P.M. Glazer MiRNA regulation of DNA repair gene expression in hypoxic stress Cancer Res 69 2009 1221 1229
117. Z. Zhang, H. Sun, and H. Dai MiRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT Cell Cycle 8 2009 2756 2768
118. Y. Chen, M. Banda, C.L. Speyer, J.S. Smith, A.B. Rabson, and D.H. Gorski Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and miRNA-221 Mol Cell Biol 30 2010 3902 3913
119. Y. Tsuchiya, M. Nakajima, S. Takagi, T. Taniya, and T. Yokoi MiRNA regulates the expression of human cytochrome P450 1B1 Cancer Res 66 2006 9090 9098
120. Y. Wang, R. Rathinam, A. Walch, and S.K. Alahari ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation J Biol Chem 284 2009 23094 23106
121. X. Li, S.U. Mertens-Talcott, S. Zhang, K. Kim, J. Ball, and S. Safe MiRNA-27a indirectly regulates estrogen receptor {alpha} expression and hormone responsiveness in MCF-7 breast cancer cells Endocrinology 151 2010 2462 2473
122. S.U. Mertens-Talcott, S. Chintharlapalli, X. Li, and S. Safe The oncogenic miRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells Cancer Res 67 2007 11001 11011
123. C.A. Gebeshuber, K. Zatloukal, and J. Martinez miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis EMBO Rep 10 2009 400 405
124. F. Wu, S. Zhu, Y. Ding, W.T. Beck, and Y.Y. Mo MiRNA-mediated regulation of Ubc9 expression in cancer cells Clin Cancer Res 15 2009 1550 1557
125. F. Yu, H. Deng, H. Yao, Q. Liu, F. Su, and E. Song Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells Oncogene 29 2010 4194 4204
126. S. Valastyan, A. Chang, N. Benaich, F. Reinhardt, and R.A. Weinberg Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis Cancer Res 70 2010 5147 5154
127. Z. Liang, H. Wu, and J. Xia Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1 Biochem Pharmacol 79 2010 817 824
128. M. Yamakuchi, M. Ferlito, and C.J. Lowenstein miR-34a repression of SIRT1 regulates apoptosis Proc Natl Acad Sci U S A 105 2008 13421 13426
129. K. Yang, A.M. Handorean, and K.A. Iczkowski MiRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro Int J Clin Exp Pathol 2 2009 361 369
130. J.L. Su, P.B. Chen, and Y.H. Chen Downregulation of miRNA miR-520h by E1A contributes to anticancer activity Cancer Res 70 2010 5096 5108
131. S.D. Reddy, S.B. Pakala, K. Ohshiro, S.K. Rayala, and R. Kumar MiRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions Cancer Res 69 2009 5639 5642
132. G. Vetter, A. Saumet, and M. Moes miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers Oncogene 29 2010 4436 4448
133. S.D. Reddy, K. Ohshiro, S.K. Rayala, and R. Kumar MiRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions Cancer Res 68 2008 8195 8200
134. R.J. Webster, K.M. Giles, K.J. Price, P.M. Zhang, J.S. Mattick, and P.J. Leedman Regulation of epidermal growth factor receptor signaling in human cancer cells by miRNA-7 J Biol Chem 284 2009 5731 5741
135. L. Ma, J. Young, and H. Prabhala miR-9, a MYC/MYCN-activated miRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol 12 2010 247 256
136. T. Kontorovich, A. Levy, M. Korostishevsky, U. Nir, and E. Friedman Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women Int J Cancer 127 2010 589 597